Better estimates of survival for patients considering adjuvant chemotherapy after surgery for early non-small-cell lung cancer.

about

Better estimates of survival for patients considering adjuvant chemotherapy after surgery for early non-small-cell lung cancer.

Item

http://www.wikidata.org/entity/Q45344139

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Better estimates of survival f ...... ly non-small-cell lung cancer.

@en

Better estimates of survival f ...... ly non-small-cell lung cancer.

@nl

type

Item

label

Better estimates of survival f ...... ly non-small-cell lung cancer.

@en

Better estimates of survival f ...... ly non-small-cell lung cancer.

@nl

prefLabel

Better estimates of survival f ...... ly non-small-cell lung cancer.

@en

Better estimates of survival f ...... ly non-small-cell lung cancer.

@nl

P1476

Better estimates of survival f ...... rly non-small-cell lung cancer

@en

P2093

M R Stockler

http://www.w3.org/2001/XMLSchema#string

P L Blinman

http://www.w3.org/2001/XMLSchema#string

P2860

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.

Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data

Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10.

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial.

Communicating prognosis in cancer care: a systematic review of the literature.

Randomised study of adjuvant chemotherapy for completely resected p-stage I-IIIA non-small cell lung cancer

Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer.

Certain death in uncertain time: informing hope by quantifying a best case scenario.

How long have I got? Estimating typical, best-case, and worst-case scenarios for patients starting first-line chemotherapy for metastatic breast cancer: a systematic review of recent randomized trials.

P304

424-429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1111/J.1445-5994.2012.02846.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

M Boyer

G J McCaughan

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22647141

http://www.w3.org/2001/XMLSchema#string